Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

NCT01444820 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

329

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: hypofractionation
RADIATION: conventional

Sponsor

Sir Mortimer B. Davis - Jewish General Hospital